Bristol-Myers Squibb
Joe Guidi is an experienced pharmaceutical and biotechnology executive currently serving as VP, Head of Medical Early Assets Innovation & Differentiation Strategy at Bristol Myers Squibb since May 2024. Prior to this role, Joe Guidi held the position of VP and Head of Early Medical Strategy and Innovation at GSK, where the focus was on shaping the oncology portfolio and establishing patient-centered evidence-based approaches. Joe Guidi's experience also includes significant leadership roles at Novartis, where responsibilities spanned early development strategies and customer marketing, and at Bayer Healthcare, developing global marketing strategies for the oncology sector. Joe Guidi began the career at GPC Biotech, playing a key role in establishing marketing infrastructure for oncology products. Joe Guidi earned a BA in Economics from Rutgers University.
This person is not in any teams
This person is not in any offices